Failure of thrombolytic therapy in patients with myocardial infarction is associated with high plasma levels of factor VII antigen.

Abstract

Thrombolytic therapy in acute myocardial infarction fails to re-establish coronary blood flow in a significant number of patients. One reason for this may be haemostatic imbalance. We investigated whether coagulation factor VII antigen (FVIIag), fibrinogen and protein C were related to reperfusion. Plasma from 45 patients was drawn before treatment and reperfusion assessed by means of continuous, on-line, vector-ECG analysis. Among the 17 patients with no reperfusion, FVIIag levels were significantly higher than among the 28 with signs of reperfusion (560 vs. 410 microg/l median, p = 0.006). Protein C levels where higher in the group with successful reperfusion (1.10 vs. 1.01 U/ml median, p = 0.03), whereas no difference was seen in fibrinogen levels. The findings were not influenced by plasma-triglycerides, body-mass index, age or time between onset of chest pain and thrombolytic therapy. The results suggest that FVII is of importance for the formation as well as resolution of coronary clots.

Cite this paper

@article{Holm1998FailureOT, title={Failure of thrombolytic therapy in patients with myocardial infarction is associated with high plasma levels of factor VII antigen.}, author={Johan Holm and Tim T{\"{o}dt and E Berntorp and Leif R. Erhardt}, journal={Thrombosis and haemostasis}, year={1998}, volume={79 5}, pages={928-31} }